CoChat

Strategies to design clinical studies to identify predictive biomarkers in cancer research

Open access
Perez-Gracia, Jose Luis, Sanmamed, Miguel F., Bosch, Ana, Patiño-Garcia, Ana, Schalper, Kurt A., Segura, Victor, Bellmunt, Joaquim, Tabernero, Josep, Sweeney, Christopher J., Choueiri, Toni K., Martín, Miguel, Fusco, Juan Pablo, Rodriguez-Ruiz, Maria Esperanza, Calvo, Alfonso, Prior, Celia, Paz-Ares, Luis, Pio, Ruben, Gonzalez-Billalabeitia, Enrique, Gonzalez Hernandez, Alvaro, Páez, David, Piulats, Jose María, Gurpide, Alfonso, Andueza, Mapi, de Velasco, Guillermo, Pazo, Roberto, Grande, Enrique, Nicolas, Pilar, Abad-Santos, Francisco, Garcia-Donas, Jesus, Castellano, Daniel, Pajares, María J., Suarez, Cristina, Colomer, Ramon, Montuenga, Luis M., Melero, Ignacio · 2017 · Cancer Treatment Reviews
Cited by 108

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

The discovery of reliable biomarkers to predict efficacy and toxicity of anticancer drugs remains one of the key challenges in cancer research. Despite its relevance, no efficient study designs to identify promising candidate biomarkers have been established. This has led to the proliferation of a myriad of exploratory studies using dissimilar strategies, most of which fail to identify any promising targets and are seldom validated. The lack of a proper methodology also determines that many anti-cancer drugs are developed below their potential, due to failure to identify predictive biomarkers. While some drugs will be systematically administered to many patients who will not benefit from them, leading to unnecessary toxicities and costs, others will never reach registration due to our inability to identify the specific patient population in which they are active. Despite these drawbacks, a limited number of outstanding predictive biomarkers have been successfully identified and validated, and have changed the standard practice of oncology. In this manuscript, a multidisciplinary panel reviews how those key biomarkers were identified and, based on those experiences, proposes a methodological framework-the DESIGN guidelines-to standardize the clinical design of biomarker identification studies and to develop future research in this pivotal field.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ctrv.2016.12.005

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 108

Metadata

Authors
Perez-Gracia, J. L., Sanmamed, M. F., Bosch, A., Patiño-Garcia, A., Schalper, K. A., Segura, V., Bellmunt, J., Tabernero, J., Sweeney, C. J., Choueiri, T. K., Martín, M., Fusco, J. P., Rodriguez-Ruiz, M. E., Calvo, A., Prior, C., Paz-Ares, L., Pio, R., Gonzalez-Billalabeitia, E., Gonzalez Hernandez, A., Páez, D., Piulats, J. M., Gurpide, A., Andueza, M., de Velasco, G., Pazo, R., Grande, E., Nicolas, P., Abad-Santos, F., Garcia-Donas, J., Castellano, D., Pajares, M. J., Suarez, C., Colomer, R., Montuenga, L. M., & Melero, I.
Venue
Cancer Treatment Reviews
Publisher
Elsevier BV
Published
2017-02
Volume
53
Pages
79-97
ISSN
0305-7372 (ISSN-L)
OpenAlex
W2564717375
Cited by
108
References
54
FWCI
14.93
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strategies to design clinical studies to identify predictive biomarkers in cancer research. https://app.cochat.ai/papers/10.1016/j.ctrv.2016.12.005
The paper
Perez-Gracia, J. L., Sanmamed, M. F., Bosch, A., Patiño-Garcia, A., Schalper, K. A., Segura, V., Bellmunt, J., Tabernero, J., Sweeney, C. J., Choueiri, T. K., Martín, M., Fusco, J. P., Rodriguez-Ruiz, M. E., Calvo, A., Prior, C., Paz-Ares, L., Pio, R., Gonzalez-Billalabeitia, E., Gonzalez Hernandez, A., . . . Melero, I. (2017). Strategies to design clinical studies to identify predictive biomarkers in cancer research. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2016.12.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.